Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants

Biomaterials

Volumn 25, Issue 14, 2004, Pages 2789-2798

  Peattie, R A ^a   Nayate, A P ^b   Firpo, M A ^c   Shelby, J ^c   Fisher, R J ^d   Prestwich, G D ^b  

^a Oregon State University   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Angiogenesis; bFGF; Cytokine; Growth factors; Hyaluronic acid; Hydrogel; VEGF

Indexed keywords

CROSSLINKING; GROWTH KINETICS; HISTOLOGY; HYDROGELS; IMPLANTS (SURGICAL); PATHOLOGY;

GROWTH FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTORS (VEGF);

BIOMATERIALS;

CYTOKINE; HYALURONIC ACID; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; EXTERNAL EAR; FILM; HYDROGEL; IMPLANT; MICROVASCULATURE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL;

EID: 1042275726     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2003.09.054     Document Type: Article

References (53)

1. Knudson C.B., Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol. 12:2001;69-78.
2. Hoekstra D. Hyaluronan-modified surfaces for medical devices. Med Dev Diagn Ind 1999;48-58.
3. Laurent T.C., Laurent U.B.G., Fraser J.R.E. Functions of hyaluronan. Ann Rheum Dis. 54:1995;429-432.
4. Farney A.C., Cho E., Schweitzer E.J., Dunkin B., Philosophe B., Colonna J., Jacobs S., Jarrell B., Flowers J.L., Bartlett S.T. Simultaneous cadaver pancreas living-donor kidney transplantation. a new approach for the type I diabetic uremic patient Ann Surg. 231:2000;696-703.
5. Aruffo A., Stamenkovic I., Mulnick M., Underhill C.B., Steed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1990;1303-1313.
6. Fraser J.R.E., Laurent T.C., Laurent U.B.G. Hyaluronan. its nature, distribution, functions and turnover J Int Med. 242:1997;27-33.
7. Dowthwaite G.P., Edwards J.C.W., Pitsillides A.A. An essential role for the interaction between hyaluronan and hyaluronan binding proteins during joint development. J Histochem Cytochem. 46:1998;641-651.
8. Collis L., Hall C., Lange I., Ziebel M.R., Prestwich G.D., Turley E.A. Rapid hyaluronan uptake is associated with enhanced motility. implications for an intracellular mode of action FEBS Lett. 440:1998;444-449.
9. Hardwick C., Hoare K., Owens R., Hohn H.P., Hook M., Moore D., Cripps V., Austen I., Nance D.M., Turley E.A. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol. 117:1992;1343-1350.
10. Entwistle J., Hall C.L., Turley E.A. Receptors. regulators of signaling to the cytoskeleton J Cell Biochem. 61:1996;569-577.
11. Lesley J., Hyman R., English N., Catterall J.B., Turner G.A. CD44 in inflammation and metastasis. Glycoconjugate J. 14:1997;611-622.
12. Prevo R., Banerji S., Ferguson D.J.P., Clasper S., Jackson D.G. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem. 276:2001;19420-19430.
13. Zhou B., Oka J.A., Singh A., Weigel P.H. Purification and subunit characterization of the rat liver endocytic hyaluronan receptor. J Biol Chem. 274:1999;33831-33834.
14. Day A.J., Prestwich G.D. Hyaluronan binding proteins. tying up the giant J Biol Chem. 277:2001;4585-4588.
15. Day A.J., Sheehan J. Hyaluronan. polysaccharide chaos to protein organization Curr Opin Struct Biol. 11:2001;617-622.
16. Toole B.P. Hyaluronan in morphogenesis. J Int Med. 242:1997;35-40.
17. Gerdin B., Hallgren R. Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation. J Int Med. 242:1997;49-55.
18. Chen W.Y.J., Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen. 7:1999;79-89.
19. Forrester J.V., Balasz E.A. Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology. 40:1980;435-446.
20. Kujawa M.J., Carrino D.A., Caplan A.I. Substrate-bonded hyaluronic acid exhibits a size-dependent stimulation of chondrogenic differentiation of stage 24 limb mesenchymal cells in culture. Dev Biol. 144:1986;519-528.
21. Goldberg R.L., Toole B.P. Hyaluronate inhibition of cell proliferation. Arthritis Rheum. 30:1987;769-778.
22. Rooney P., Kumar S., Ponting J., Wang M. The role of hyaluronan in tumor neovascularization. Int J Cancer. 60:1995;632-636.
23. West D.C., Kumar S. The effects of hyaluronate and it oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res. 183:1989;179-196.
24. Sattar A., Kumar S., West D.C. Does hyaluronan have a role in endothelial cell proliferation in the synovium? Semin Arthritis Rheum. 22:1992;37-43.
25. Sattar A., Rooney P., Kumar S., Pye D., West D.C., Scott I., Ledger P. Application of angiogenic oligosaccharides of hyaluronan increase blood vessel numbers in skin. J Invest Dermatol. 103:1994;573-579.
26. West D.C., Hampson I.N., Arnold F., Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science. 228:1985;1324-1326.
27. Lees V.C., Fan T-.P.D., West D.C. Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab Invest. 73:1995;259-266.
28. Montesano R., Kumar S., Orci L., Pepper M.S. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Lab Invest. 75:1996;249-262.
29. Suhardja A., Hoffman H. Role of growth factors and their receptors in proliferation of microvascular endothelial cells. Microsc Res Tech. 60:2003;70-75.
30. Ribatti D., Presta M. The role of fibroblast growth factor-2 in the vascularization of the chick embryo chorioallantoic membrane. J Cell Mol Med. 6:2002;439-446.
31. Liekens S. The role of growth factors, angiogenic enzymes and apoptosis in neovascularization and tumor growth-collected publications. Verh K Acad Geneeskd Belg. 64:2002;197-224.
32. Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis. therapeutic implications Semin Oncol. 29:2002;10-14.
33. Jain R.K. Tumor angiogenesis and accessibility. role of vascular endothelial growth factor Semin Oncol. 29:2002;3-9.
34. Goth M.I., Hubina E., Raptis S., Nagy G.M., Toth B.E. Physiological and pathological angiogenesis in the endocrine system. Microsc Res Tech. 60:2003;98-106.
35. Carmeliot P. Angiogenesis in Health and Disease. Nat Med. 9:2003;653-660.
36. Ferrara N., Gerber H-.P., LeCouter J. The biology of VEGF and its receptors. Nat Med. 9:2003;669-676.
37. Paku S., Paweletz N. First steps of tumor-related angiogenesis. Lab Invest. 65:1991;334-346.
38. Nikosia R.F., Bonanno E., Smith M., Yurchenco P. Modulation of angiogenesis in vitro by laminin-entactin complex. Dev Biol. 164:1994;197-206.
39. Ingber D.E., Folkmann J. Mechano-chemical switching between growth and differentiation during growth factor-stimulated angiogenesis in vitro. role of the extracellular matrix J Cell Biol. 109:1989;317-330.
40. Luo Y., Kirker K.R., Prestwich G.D. Cross-linked hyaluronic acid hydrogel films. new biomaterials for drug delivery J Control Release. 69:2000;169-184.
41. Luo Y., Prestwich G.D. Hyaluronic acid-N-hydroxysuccinimide. a useful intermediate for bioconjugation Bioconjugugate Chem. 12:2001;1085-1088.
42. Luo Y., Ziebell M.R., Prestwich G.D. A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules. 1:2000;208-218.
43. Kirker K.R., Luo Y., Nielson J.H., Shelby J., Prestwich G.D. Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing. Biomaterials. 23:2002;3661-3671.
44. Forbes K., Webb M.A., Sehgal I. Growth factor regulation of secreted matrix metalloproteinase and plasminogen activators in prostate cancer cells, normal prostate fibroblasts and normal osteoblasts. Prostate Cancer Prostatic Dis. 6:2003;148-153.
45. Kim M.H. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. J Cell Biochem. 89:2003;529-538.
46. Yabushita H., Shimazu M., Noguchi M., Kishida T., Narumiya H., Sawaguchi K., Noguchi M. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Oncol Rep. 10:2003;89-95.
47. Wagner S., Fueller T., Hummel V., Rieckmann P., Tonn J.C. Influence of VEGF-R2 inhibition on MMP secretion and motility of microvascular human cerebral endothelial cells (HCEC). J Neurooncol. 62:2003;221-231.
48. Lee K.Y., Peters M.C., Anderson K.W., Mooney D.J. Controlled growth factor release from synthetic extracellular matrices. Nature. 408:2000;998-1000.
49. Richardson T.P., Peters M.C., Ennett A.B., Mooney D.J. Polymeric system for dual growth factor delivery. Nature Biotech. 19:2001;1029-1034.
50. Gillis P., Savia U., Volpert O.V., Jimenez B., Waters C.M., Panos R.J., Bouck N.P. Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function. J Cell Sci. 112:1999;2049-2057.
51. Rokstad A.M., Holtan S., Strand B., Steinkjer B., Ryan I., Kulseng R., Skjak-Braek G., Espevik T. Microencapsulation of cells producing therapeutic proteins. optimizing cell growth and secretion Cell Transplant. 11:2002;313-324.
52. Luo P., Hayes R.J., Chan C., Stark D.M., Hwang M.Y., Jacinto J.M., Jovvadi P., Chung H.S., Kundu A., Ary M.I., Dubiyat B.I. Development of a cytokine analog with enhanced stability using computational ultrahigh throughput screening. Protein Sci. 11:2002;1218-1226.
53. Kanaoka F., Takahashi K., Yoshikawa T., Jizomoto H., Nishihara Y., Hirano K. A novel and simple type of liposome carrier for recombinant interleukin-2. J Pharm Pharmacol. 53:2001;295-302.